| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Options Exercise | $10,958,899 | +285,388 | +130% | $38.40 | 505,447 | 05 Feb 2025 | Direct | |
| transaction | ABT | Common shares without par value | Sale | $37,435,200 | -285,388 | -56% | $131.17 | 220,059 | 05 Feb 2025 | Direct | F1 |
| holding | ABT | Common shares without par value | 197,403 | 05 Feb 2025 | Ford Family Trust | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Option (right to buy) | Options Exercise | $0 | -285,388 | -100% | $0.000000 | 0 | 05 Feb 2025 | Common Shares | 285,388 | $38.40 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.68 to $131.38, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F2 | Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust. |
| F3 | Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |